Competition authorities in 13 countries have now asked the EU Commission to examine Demant’s potential sale of Oticon Medical to Cochlear.
The best research comes from curiosity, not personal ambition, says one of the three recipients of Nobel Prize in Chemistry.
The FDA has just approved a drug licensed by Forma Therapeutics, which Novo Nordisk acquired in September. Royalties from the newly approved cancer treatment will total 13-35% of sales.
After a challenging launch of Wegovy, where Novo Nordisk couldn’t keep up with skyrocketing demand, the pharmaceutical firm is making a large investment to increase production.
Niels Peter Louis-Hansen has bought 56,770 shares in the medtech firm through his company, Aage og Johanne Louis-Hansen.
Danish biotech firm Forward Pharma’s appeal has been rejected in a long running case against US-based Biogen.
Biogen and its partner Sage Therapeutics have now completed the rolling submission process for their depression drug zuranolon at the US Food and Drug Administration.
Christmas has come early for GSK, Sanofi and Pfizer, as 5000 claims that their heartburn medication Zantac causes cancer have been thrown out by a US judge.
Shortly after the potential sale of Demant’s Oticon Medical division to Cochlear raised eyebrows at the Australian competition authorities, the UK competition council reveals it is also less than happy about the idea.
Topline data from a phase III trial of delgocitinib, a JAK inhibitor treatment for severe chronic hand eczema, was positive for Leo Pharma.
The US Food and Drug Administration (FDA) will soon take a more hardline stance on drugs with fast-track status, the Wall Street Journal reports.
Over the next year, the world’s largest distributor of hearing aids will conduct a particularly aggressive strategy in the US, as it sees the uncertain inflationary environment as an opportunity to grow.
The US joins nearly three dozen nations in seeking more time and information about a potential waiver extension.
A new grant aims to accelerate the development of new RNA-based vaccines against infectious diseases. The goal is spinouts and partnerships, says the leader of the research program.
From next year onwards, companies will be able to launch patent applications through a shared European court. That comes with opportunities, but there are risks as well, say lawyers and advisors.
The hearing aid giant now owns over 200 hearing clinics in China.
In an analyst note, Danske Bank predicts that Novo Nordisk and Eli Lilly will snap up the biggest shares of the obesity treatment market, even though lots of companies are ready to pounce.
The pharmaceutical arm of Johnson & Johnson has bowed out of the race to acquire Horizon Therapeutics, which sells Genmab’s best-selling eye treatment Tepezza.
The three firms, which all have production facilities in the country, appear to be benefitting from the relaxation of China’s zero-tolerance Covid-19 policy.
The US Health Authorities are ready to declare the public emergency over as cases of mpox, formerly known as monkeypox, plummet.
Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.
The US Food and Drug Administration has officially rejected a Y-mabs cancer drug, after it was voted down by a sub-committee in October.
Miss anything?
Coloplast aims to grow by 10%, and chairman of the board Lars Rasmussen thinks this will be realized through multiple acquisitions.
Ferring Pharmaceuticals has received US approval for its stomach infection treatment.
Quality Assurance Specialist (QAS) in dietary supplements 
External Manufacturing Leads 
Medical Manager Denmark & Norway Quality Compliance Specialist 
Project Director of CMC & Device, Zealand Pharma A/S / 1801 
(Senior) CMC Project Manager 
Senior or Principal Scientist – Preclinical Biology Quality Compliance Specialist - Herbal Medicines and Medical Devices Nordic Medical Manager, Central Nervous System 
Laboratory assistants for an exciting QC department Head Of Business Unit Pharma, Öresund Region, AFRY 
Systems Verification Manager for Embedded Medical Solutions 
Associate Director, Global Drug Safety and Pharmacovigilance Scientist QA Specialist Director, QA Commercial Drug Substance, Ascendis Pharma Specialist, Regulatory Affairs Principal Systems Engineer Associated Director Device Development and Support Global CMC Development, ALK Head of Engineering 
Consultants for FIERS - will you create unique healthcare collaborations? - FIERS - Copenhagen / Denmark Research Scientist (maternity cover) Head of Regulatory Affairs Danmark 
Chief consultant for Dansk Erhvervs Health and life science 
Supply Chain Manager 
